Related references
Note: Only part of the references are listed.Effects of statins on the biological features of mesenchymal stem cells and therapeutic implications
Armita Mahdavi Gorabi et al.
HEART FAILURE REVIEWS (2021)
Does adherence to lipid-lowering medications improve cancer survival? A nationwide study of breast and colorectal cancer, and melanoma
Jia-Li Feng et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Lipid-lowering medication use and cancer-specific survival among endometrial or lung cancer patients: an Australian nationwide cohort study
Jia-Li Feng et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)
Statins as Potential Therapeutics for Esophageal Cancer
Ali Fatehi Hassanabad et al.
JOURNAL OF GASTROINTESTINAL CANCER (2021)
Statin therapy and postoperative short-term mortality after rectal cancer surgery
Arvid Pourlotfi et al.
COLORECTAL DISEASE (2021)
Phase 2 trial comparing sorafenib, pravastatin, their combination or supportive care in HCC with Child-Pugh B cirrhosis
Jean-Frederic Blanc et al.
HEPATOLOGY INTERNATIONAL (2021)
Polypill with or without Aspirin in Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
High-intensity statins are associated with improved clinical activity of PD-1 inhibitors in malignant pleural mesothelioma and advanced non-small cell lung cancer patients
Luca Cantini et al.
EUROPEAN JOURNAL OF CANCER (2021)
Immortal Time Bias in Observational Studies
Kabir Yadav et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2021)
Effect of combined acetylsalicylic acid and statins treatment on intracranial aneurysm rupture
Mikel Terceno et al.
PLOS ONE (2021)
Statin use and risk of prostate cancer biochemical recurrence after radical prostatectomy
Nicole Prabhu et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2021)
Is the Benefit of Antithrombotics and Statins Worth the Risk of Intracerebral Hemorrhage? It Depends
Jose Gutierrez
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2021)
Cytotoxic and Pro-Apoptotic Effects of a Sub-Toxic Concentration of Fluvastatin on OVCAR3 Ovarian Cancer Cells After its Optimized Formulation to Melittin Nano-Conjugates
Shaimaa M. Badr-Eldin et al.
FRONTIERS IN PHARMACOLOGY (2021)
The Mevalonate Pathway, a Metabolic Target in Cancer Therapy
Borja Guerra et al.
FRONTIERS IN ONCOLOGY (2021)
Statins Attenuate Fibrotic Manifestations of Cardiac Tissue Damage
Armita M. Gorabi et al.
CURRENT MOLECULAR PHARMACOLOGY (2021)
Rosuvastatin Nanomicelles Target Neuroinflammation and Improve Neurological Deficit in a Mouse Model of Intracerebral Hemorrhage
Liu Zi et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2021)
Combination of Simvastatin and FAC Improves Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer
Erwin Danil Yulian et al.
CANCER RESEARCH AND TREATMENT (2021)
Association of statin use with clinical outcomes in patients with triple-negative breast cancer
Malgorzata K. Nowakowska et al.
CANCER (2021)
Effect of statins on functional outcome and mortality following aneurysmal subarachnoid hemorrhage - Results of a meta-analysis, metaregression and trial sequential analysis
Sandeep Bohara et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2021)
Statins: a repurposed drug to fight cancer
Wen Jiang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2021)
Association of Metabolic Syndrome and Its Components With Risk of Stroke Recurrence and Mortality A Meta-analysis
Fangfang Zhang et al.
NEUROLOGY (2021)
Influence of cholesterol on cancer progression and therapy
Shyamananda Singh Mayengbam et al.
TRANSLATIONAL ONCOLOGY (2021)
Statin Use and Outcomes of Patients With Acute Ischemic Stroke Treated With Intravenous Thrombolysis: A Systematic Review and Meta-Analysis
Yu Guo et al.
FRONTIERS IN NEUROLOGY (2021)
Role of Blood Lipid Levels and Lipid-Lowering Therapy in Stroke Patients with Different Levels of Cerebral Artery Diseases: Reconsidering Recent Stroke Guidelines
Jong S. Kim
JOURNAL OF STROKE (2021)
Statin-mediated inhibition of RAS prenylation activates ER stress to enhance the immunogenicity of KRAS mutant cancer
Gi-Hoon Nam et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
The Protective Effects of Statins towards Vessel Wall Injury Caused by a Stent Retrieving Mechanical Throm-bectomy Device : A Histological Analysis of the Rabbit Carotid Artery Model
Seung Hwan Lee et al.
JOURNAL OF KOREAN NEUROSURGICAL SOCIETY (2021)
Small Unruptured Aneurysm Verification-prevention Effect against Growth of Cerebral Aneurysm Study Using Statin
Kazumichi Yoshida et al.
NEUROLOGIA MEDICO-CHIRURGICA (2021)
Statin treatment and cerebral microbleeds: A systematic review and meta-analysis
Aristeidis H. Katsanos et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2021)
The impact of statin therapy after surgical or endovascular treatment of cerebral aneurysms
Tae-Jin Song et al.
JOURNAL OF NEUROSURGERY (2020)
Atorvastatin in combination with conventional antimicrobial treatment of Helicobacter pylori eradication: A randomized controlled clinical trial
Seyed Saeed Sarkeshikian et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2020)
Statin use and longitudinal changes in prostate volume; results from the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial
Emma H. Allott et al.
BJU INTERNATIONAL (2020)
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)
Francois Mach et al.
EUROPEAN HEART JOURNAL (2020)
Chemoprevention of Colorectal Cancer
Bryson W. Katona et al.
GASTROENTEROLOGY (2020)
Atorvastatin reduces cerebral vasospasm and infarction after aneurysmal subarachnoid hemorrhage in elderly Chinese adults
Junhui Chen et al.
AGING-US (2020)
Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Helicobacter Pylori Infection: A Territory-Wide Propensity Score Matched Study
Ka Shing Cheung et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2020)
Receipt of Statins Is Associated With Lower Risk of Multiple Myeloma: Systematic Review and Meta-analysis
Ben Ponvilawan et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2020)
Drug Development for Central Nervous System Diseases Using In vitro Blood-brain Barrier Models and Drug Repositioning
Yoichi Morofuji et al.
CURRENT PHARMACEUTICAL DESIGN (2020)
Statin treatment and accrual of covert cerebral ischaemia on neuroimaging: a systematic review and meta-analysis of randomized trials
A. H. Katsanos et al.
EUROPEAN JOURNAL OF NEUROLOGY (2020)
Statin use and the risk of renal cell carcinoma: national cohort study
Yu-Ching Chou et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2020)
Regulation of Small GTPase Prenylation in the Nervous System
Jairus M. Reddy et al.
MOLECULAR NEUROBIOLOGY (2020)
Statin treatment can reduce incidence of early seizure in acute ischemic stroke: A propensity score analysis
Soichiro Matsubara et al.
SCIENTIFIC REPORTS (2020)
Statins use and its impact in EGFR-TKIs resistance to prolong the survival of lung cancer patients: A Cancer registry cohort study in Taiwan
Phung-Anh Nguyen et al.
CANCER SCIENCE (2020)
Statin use and the risk of multiple myeloma: a PRISMA-compliant meta-analysis
Pengcheng Zhang et al.
ANNALS OF HEMATOLOGY (2020)
K-Ras prenylation as a potential anticancer target
Marcell Baranyi et al.
CANCER AND METASTASIS REVIEWS (2020)
Efficacy and Safety of the Combination of Pravastatin and Sorafenib for the Treatment of Advanced Hepatocellular Carcinoma (ESTAHEP Clinical Trial)
Ioana Riano et al.
CANCERS (2020)
A Prospective, Randomized, Placebo-Controlled Study of a Combination of Simvastatin and Chemotherapy in Metastatic Breast Cancer
Hiba Alarfi et al.
JOURNAL OF ONCOLOGY (2020)
Statins as Anticancer Agents in the Era of Precision Medicine
Joseph Longo et al.
CLINICAL CANCER RESEARCH (2020)
Antiviral effects of statins
Armita M. Gorabi et al.
PROGRESS IN LIPID RESEARCH (2020)
Effect of comorbidities/comedications on sunitinib outcomes for metastatic renal cell carcinoma: the STAR-TOR registry
Martin Boegemann et al.
FUTURE ONCOLOGY (2020)
Cholesterol, carotid artery disease and stroke: what the vascular specialist needs to know
Kosmas I. Paraskevas et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Pleiotropic effects of statins: A focus on cancer
Mazaher Ahmadi et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2020)
Effects of atorvastatin and aspirin on post-stroke epilepsy and usage of levetiracetam
Teng Zhao et al.
MEDICINE (2020)
The predictors and prognosis for unexpected reocclusion after mechanical thrombectomy: a meta-analysis
Xiangyu Li et al.
ANNALS OF TRANSLATIONAL MEDICINE (2020)
Lipid Metabolism and Resistance to Anticancer Treatment
Nicolas Germain et al.
BIOLOGY-BASEL (2020)
Prospective Evaluation of Malignancy in 17,708 Patients Randomized to Ezetimibe Versus Placebo Analysis From IMPROVE-IT
Robert P. Giugliano et al.
JACC: CARDIOONCOLOGY (2020)
Integrated analysis of concomitant medications and oncological outcomes from PD-1/PD-L1 checkpoint inhibitors in clinical practice
Alessio Cortellini et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2020)
Adjuvant statin therapy for oesophageal adenocarcinoma: the STAT-ROC feasibility study
L. Alexandre et al.
BJS OPEN (2020)
Bladder cancer risk in users of selected drugs for cardiovascular disease prevention
Valentina Guercio et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2019)
Atorvastatin inhibits pro-inflammatory actions of aldosterone in vascular smooth muscle cells by reducing oxidative stress
Thiago Bruder-Nascimento et al.
LIFE SCIENCES (2019)
HMG-CoA Reductase Inhibitors Attenuate Neuronal Damage by Suppressing Oxygen Glucose Deprivation-Induced Activated Microglial Cells
Dan Lu et al.
NEURAL PLASTICITY (2019)
Pravastatin combination with sorafenib does not improve survival in advanced hepatocellular carcinoma
Jean-Louis Jouve et al.
JOURNAL OF HEPATOLOGY (2019)
Efficacy of Statins in Cerebral Vasospasm, Mortality, and Delayed Cerebral Ischemia in Patients with Aneurysmal Subarachnoid Hemorrhage: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Jianguo Shen et al.
WORLD NEUROSURGERY (2019)
Statins for neuroprotection in spontaneous intracerebral hemorrhage
Ching-Jen Chen et al.
NEUROLOGY (2019)
Efficacy of Statin therapy in post-stroke seizure prophylaxis: Clues from an observational study of routine secondary prevention treatment
Yuxiang Li et al.
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)
Twenty-Four-Hour Reocclusion After Successful Mechanical Thrombectomy: Associated Factors and Long-Term Prognosis
Joao Pedro Marto et al.
STROKE (2019)
Statin Safety and Associated Adverse Events: A Scientific Statement From the American Heart Association
Connie B. Newman et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)
Statin use and breast cancer survival - a Swedish nationwide study
Signe Borgquist et al.
BMC CANCER (2019)
Cardioprotective Effect of Statins in Patients With HER2-Positive Breast Cancer Receiving Trastuzumab Therapy
Oscar Calvillo-Arguelles et al.
CANADIAN JOURNAL OF CARDIOLOGY (2019)
SPAR - a randomised, placebo-controlled phase II trial of simvastatin in addition to standard chemotherapy and radiation in preoperative treatment for rectal cancer: an AGITG clinical trial
Michael B. Jameson et al.
BMC CANCER (2019)
Topical atorvastatin 1% for prevention of skin toxicity in patients receiving radiation therapy for breast cancer: a randomized, double-blind, placebo-controlled trial
Arash Ghasemi et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2019)
Effect of Rosuvastatin in Preventing Chemotherapy-Induced Cardiotoxicity in Women With Breast Cancer: A Randomized, Single-Blind, Placebo-Controlled Trial
Maryam Nabati et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY AND THERAPEUTICS (2019)
Association between occurrence of urinary bladder cancer and treatment with statin medication
Erik Lundberg et al.
TURKISH JOURNAL OF UROLOGY (2019)
Long-acting statin for aneurysmal subarachnoid hemorrhage: A randomized, double-blind, placebo-controlled trial
Masato Naraoka et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2018)
Protective effects of atorvastatin on cerebral vessel autoregulation in an experimental rabbit model of subarachnoid hemorrhage
Jun-Hui Chen et al.
MOLECULAR MEDICINE REPORTS (2018)
Atorvastatin ameliorates early brain injury through inhibition of apoptosis and ER stress in a rat model of subarachnoid hemorrhage
Wentao Qi et al.
BIOSCIENCE REPORTS (2018)
Statins: a role in breast cancer therapy?
S. Borgquist et al.
JOURNAL OF INTERNAL MEDICINE (2018)
Report of the relapsed/refractory cohort of SWOG S0919: A phase 2 study of idarubicin and cytarabine in combination with pravastatin for acute myelogenous leukemia (AML)
Anjali S. Advani et al.
LEUKEMIA RESEARCH (2018)
Association of statin use with spontaneous intracerebral hemorrhage A cohort study
Walid Saliba et al.
NEUROLOGY (2018)
Lipid-Lowering Agents and High HDL (High-Density Lipoprotein) Are Inversely Associated With Intracranial Aneurysm Rupture
Anil Can et al.
STROKE (2018)
The Epidemiology of Prostate Cancer
Claire H. Pernar et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2018)
HMG-CoA Reductase Inhibitors Relieve Endoplasmic Reticulum Stress by Autophagy Inhibition in Rats With Permanent Brain Ischemia
Tao Zhang et al.
FRONTIERS IN NEUROSCIENCE (2018)
Examining Bias in Studies of Statin Treatment and Survival in Patients With Cancer
Louise Emilsson et al.
JAMA ONCOLOGY (2018)
Atorvastatin Pretreatment Attenuates Ischemic Brain Edema by Suppressing Aquaporin 4
Zhi-Juan Cheng et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Incidence of new onset cancer in patients with a myocardial infarction - a nationwide cohort study
Morten Malmborg et al.
BMC CARDIOVASCULAR DISORDERS (2018)
Statin-Induced Cancer Cell Death Can Be Mechanistically Uncoupled from Prenylation of RAS Family Proteins
Rosemary Yu et al.
CANCER RESEARCH (2018)
Serum cholesterol and risk of lower urinary tract symptoms progression: Results from the Reduction by Dutasteride of Prostate Cancer Events study
Tom Feng et al.
INTERNATIONAL JOURNAL OF UROLOGY (2017)
Statin use and all-cause and cancer mortality: BioBank Japan cohort
Hiroshi Yokomichi et al.
JOURNAL OF EPIDEMIOLOGY (2017)
Clinical evidence of efficacy of simvastatin for aneurysmal subarachnoid hemorrhage
Jinghui Lin et al.
JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)
Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial
Paul M. Ridker et al.
LANCET (2017)
Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway
Vasanthi S. Viswanathan et al.
NATURE (2017)
SREBP-regulated lipid metabolism: convergent physiology - divergent pathophysiology
Hitoshi Shimano et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Statin improves survival in patients with EGFR-TKI lung cancer: A nationwide population-based study
Ming-Szu Hung et al.
PLOS ONE (2017)
Randomized Controlled Trial of Early Versus Delayed Statin Therapy in Patients With Acute Ischemic Stroke ASSORT Trial (Administration of Statin on Acute Ischemic Stroke Patient)
Shinichi Yoshimura et al.
STROKE (2017)
Effect of statins as a secondary chemopreventive agent among individuals with non-muscle-invasive bladder cancer: A population-based analysis
Patrick O. Richard et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2017)
Randomized Phase II Study of Afatinib Plus Simvastatin Versus Afatinib Alone in Previously Treated Patients with Advanced Nonadenocarcinomatous Non-small Cell Lung Cancer
Youngjoo Lee et al.
CANCER RESEARCH AND TREATMENT (2017)
Statin Use, Serum Lipids, and Prostate Inflammation in Men with a Negative Prostate Biopsy: Results from the REDUCE Trial
Emma H. Allott et al.
CANCER PREVENTION RESEARCH (2017)
Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis
Kosuke Tanaka et al.
CANCER LETTERS (2017)
Pleiotropic Effects of Statins on the Cardiovascular System
Adam Oesterle et al.
CIRCULATION RESEARCH (2017)
Statin use and breast cancer survival: a nationwide cohort study in Scotland
Una C. Mc Menamin et al.
BMC CANCER (2016)
Long-Term Safety and Efficacy of Lowering Low-Density Lipoprotein Cholesterol With Statin Therapy 20-Year Follow-Up of West of Scotland Coronary Prevention Study
Ian Ford et al.
CIRCULATION (2016)
Can atorvastatin with metformin change the natural history of prostate cancer as characterized by molecular, metabolomic, imaging and pathological variables? A randomized controlled trial protocol
Matthew J. Roberts et al.
CONTEMPORARY CLINICAL TRIALS (2016)
Atorvastatin ameliorates early brain injury after subarachnoid hemorrhage via inhibition of AQP4 expression in rabbits
Jun-Hui Chen et al.
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)
Pleiotropic effects of statins: new therapeutic targets in drug design
Onkar Bedi et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2016)
Cholesterol Lowering in Intermediate-Risk Persons without Cardiovascular Disease
S. Yusuf et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Meta-analysis of studies using statins as a reducer for primary liver cancer risk
Guo-Chao Zhong et al.
SCIENTIFIC REPORTS (2016)
A randomised, double-blind, placebo-controlled multi-centre phase III trial of XELIRI/FOLFIRI plus simvastatin for patients with metastatic colorectal cancer
S. H. Lim et al.
BRITISH JOURNAL OF CANCER (2015)
Vascular injury in diabetic db/db mice is ameliorated by atorvastatin: role of Rac1/2-sensitive Nox-dependent pathways
Thiago Bruder-Nascimento et al.
CLINICAL SCIENCE (2015)
The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications
Marcello Maugeri-Sacca et al.
EXPERT REVIEWS IN MOLECULAR MEDICINE (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statin-induced anti-proliferative effects via cyclin D1 and p27 in a window-of-opportunity breast cancer trial
Maria Feldt et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points
Lisa J. Martin et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Statins use and the risk of all and subtype hematological malignancies: a meta-analysis of observational studies
Danitza Pradelli et al.
CANCER MEDICINE (2015)
The Japan Statin Treatment Against Recurrent Stroke (J-STARS): A Multicenter, Randomized, Open-label, Parallel-group Study
Naohisa Hosomi et al.
EBIOMEDICINE (2015)
Metabolic syndrome-like components and prostate cancer risk: results from the Reduction by Dutasteride of Prostate Cancer Events (REDUCE) study
Katharine N. Sourbeer et al.
BJU INTERNATIONAL (2015)
Incidence of Cancer and Mortality in Patients from the Simvastatin and Ezetimibe in Aortic Stenosis (SEAS) Trial
Anders Green et al.
AMERICAN JOURNAL OF CARDIOLOGY (2014)
Effect of Simvastatin on Physiological and Biological Outcomes in Patients Undergoing Esophagectomy A Randomized Placebo-Controlled Trial
Murali Shyamsundar et al.
ANNALS OF SURGERY (2014)
Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells
Carolyn A. Goard et al.
BREAST CANCER RESEARCH AND TREATMENT (2014)
Statin use and risk of kidney cancer: a meta-analysis of observational studies and randomized trials
Xiao-long Zhang et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2014)
SWOG0919: a Phase 2 study of idarubicin and cytarabine in combination with pravastatin for relapsed acute myeloid leukaemia
Anjali S. Advani et al.
BRITISH JOURNAL OF HAEMATOLOGY (2014)
Association between statin use and colorectal cancer risk: a meta-analysis of 42 studies
Yanqiong Liu et al.
CANCER CAUSES & CONTROL (2014)
Randomized double-blinded, placebo-controlled phase II trial of simvastatin and gemcitabine in advanced pancreatic cancer patients
Jung Yong Hong et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
A Randomized, Double-Blind, Placebo-Controlled Phase II Clinical Trial of Lovastatin for Various Endpoints of Melanoma Pathobiology
Kenneth G. Linden et al.
CANCER PREVENTION RESEARCH (2014)
Simvastatin plus capecitabine-cisplatin versus placebo plus capecitabine-cisplatin in patients with previously untreated advanced gastric cancer: A double-blind randomised phase 3 study
Seung Tae Kim et al.
EUROPEAN JOURNAL OF CANCER (2014)
Very Low Levels of Atherogenic Lipoproteins and the Risk for Cardiovascular Events A Meta-Analysis of Statin Trials
S. Matthijs Boekholdt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Innate and Adaptive Inflammation as a Therapeutic Target in Vascular Disease
Dimitris Tousoulis et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
The Association between Statin Medication and Progression after Surgery for Localized Renal Cell Carcinoma
Robert J. Hamilton et al.
JOURNAL OF UROLOGY (2014)
Statin Use Is Not Associated with Improved Progression Free Survival in Cetuximab Treated KRAS Mutant Metastatic Colorectal Cancer Patients: Results from the CAIRO2 Study
Lisanne L. Krens et al.
PLOS ONE (2014)
The pharmacology of statins
Cesare R. Sirtori
PHARMACOLOGICAL RESEARCH (2014)
Interplay of mevalonate and Hippo pathways regulates RHAMM transcription via YAP to modulate breast cancer cell motility
Zhongyuan Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Baseline Very Low-Density Lipoprotein Cholesterol is Associated with the Magnitude of Triglyceride Lowering on Statins, Fenofibric Acid, or Their Combination in Patients with Mixed Dyslipidemia
Abhinav Sharma et al.
JOURNAL OF CARDIOVASCULAR TRANSLATIONAL RESEARCH (2014)
Effects of statins-use for patients with aneurysmal subarachnoid hemorrhage: a meta-analysis of randomized controlled trials
Shao-Hua Su et al.
SCIENTIFIC REPORTS (2014)
Statin-induced mevalonate pathway inhibition attenuates the growth of mesenchymal-like cancer cells that lack functional E-cadherin mediated cell cohesion
Katsuhiko Warita et al.
SCIENTIFIC REPORTS (2014)
Statin use and risk of liver cancer: an update meta-analysis
Meng Shi et al.
BMJ OPEN (2014)
Statins are associated with reduced risk of gastric cancer: a systematic review and meta-analysis
P. P. Singh et al.
ANNALS OF ONCOLOGY (2013)
Neuroprotective Effect of Atorvastatin Involves Suppression of TNF-α and Upregulation of IL-10 in a Rat Model of Intracerebral Hemorrhage
Tu Ewen et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2013)
Statins Are Associated With Reduced Risk of Esophageal Cancer, Particularly in Patients With Barrett's Esophagus: A Systematic Review and Meta-analysis
Siddharth Singh et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2013)
Statins and primary liver cancer: a meta-analysis of observational studies
Danitza Pradelli et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2013)
Statins are associated with reduced risk of gastric cancer: A meta-analysis
Xiao-Dan Wu et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2013)
Managing the residual cardiovascular disease risk associated with HDL-cholesterol and triglycerides in statin-treated patients: A clinical update
Z. Reiner
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2013)
Statins and the Risk of Lung Cancer: A Meta-Analysis
Min Tan et al.
PLOS ONE (2013)
Association between Statin Usage and Prostate Cancer Prevention: A Refined Meta-Analysis Based on Literature from the Years 2005-2010
Yong Zhang et al.
UROLOGIA INTERNATIONALIS (2013)
Effects of statins on the prognosis of local and locally advanced renal cell carcinoma following nephrectomy
Seung-Kwon Choi et al.
MOLECULAR AND CLINICAL ONCOLOGY (2013)
Randomised clinical trial: simvastatin as adjuvant therapy improves significantly the Helicobacter pylori eradication rate - a placebo-controlled study
W. Nseir et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2012)
Statin use and risk of breast cancer: a meta-analysis of observational studies
Krishna Undela et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Statin use and the risk of renal cell carcinoma in 2 prospective US cohorts
Wei Liu et al.
CANCER (2012)
Nonsteroidal anti-inflammatory drugs and the risk of skin cancer
Sigrun Alba Johannesdottir et al.
CANCER (2012)
Statin use and risk of pancreatic cancer: a meta-analysis
Xiaobing Cui et al.
CANCER CAUSES & CONTROL (2012)
Effects of Atorvastatin on Pathological Changes in Brain Tissue and Plasma MMP-9 in Rats with Intracerebral Hemorrhage
Jing-Jing Cui et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2012)
Statin Use and Risk of Prostate Cancer: A Meta-Analysis of Observational Studies
Dipika Bansal et al.
PLOS ONE (2012)
Statin Use During Ischemic Stroke Hospitalization Is Strongly Associated With Improved Poststroke Survival
Alexander C. Flint et al.
STROKE (2012)
Relation Between Serum Total Cholesterol Level and Cardiovascular Disease Stratified by Sex and Age Group: A Pooled Analysis of 65 594 Individuals From 10 Cohort Studies in Japan
Sin-ya Nagasawa et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2012)
Statins Are Associated With a Reduced Risk of Gastric Cancer: A Population-Based Case-Control Study
Hui-Fen Chiu et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2011)
Thalidomide, dexamethasone and lovastatin with autologous stem cell transplantation as a salvage immunomodulatory therapy in patients with relapsed and refractory multiple myeloma
Marek Hus et al.
ANNALS OF HEMATOLOGY (2011)
Statins and Intracerebral Hemorrhage Collaborative Systematic Review and Meta-Analysis
Daniel G. Hackam et al.
CIRCULATION (2011)
A Randomized Phase II Study of Gefitinib Plus Simvastatin Versus Gefitinib Alone in Previously Treated Patients with Advanced Non-Small Cell Lung Cancer
Ji-Youn Han et al.
CLINICAL CANCER RESEARCH (2011)
Relationship Between Statin Use and Colon Cancer Recurrence and Survival: Results From CALGB 89803
Kimmie Ng et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Pleiotropic Effects of Statins - Basic Research and Clinical Perspectives
Qian Zhou et al.
CIRCULATION JOURNAL (2010)
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial
Inge R. H. M. Konings et al.
EUROPEAN JOURNAL OF CANCER (2010)
Effect of statins on HDL-C: a complex process unrelated to changes in LDL-C: analysis of the VOYAGER Database
Philip J. Barter et al.
JOURNAL OF LIPID RESEARCH (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Cholesterol-lowering and cancer in the prevention of cardiovascular disease
M. F. Oliver
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2010)
Antiplatelet Actions of Statins and Fibrates Are Mediated by PPARs
Ferhana Y. Ali et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2009)
Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol and the incidence of cardiovascular disease in an urban Japanese cohort study: The Suita study
Tomonori Okamura et al.
ATHEROSCLEROSIS (2009)
Biologic effects of simvastatin in patients with aneurysmal subarachnoid hemorrhage: a double-blind, placebo-controlled randomized trial
Mervyn D. I. Vergouwen et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2009)
Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial
Paul M. Ridker et al.
LANCET (2009)
Primary prevention of cardiovascular disease with statins: cautionary notes
M. R. Goldstein et al.
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE (2009)
Therapeutic approach against intimal hyperplasia of vein grafts through endothelial nitric oxide synthase/nitric oxide (eNOS/NO) and the Rho/Rho-kinase pathway
Masayuki Sugimoto et al.
SURGERY TODAY (2009)
Statin use and risk of prostate cancer: Results from a population-based epidemiologic study
Ilir Agalliu et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Impact of Genetic Polymorphisms of Transporters on the Pharmacokinetic, Pharmacodynamic and Toxicological Properties of Anionic Drugs
Kazuya Maeda et al.
DRUG METABOLISM AND PHARMACOKINETICS (2008)
Statins, low-density lipoprotein cholesterol, and risk of cancer
Alawi A. Alsheikh-Ali et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Primary Prevention of Cardiovascular Mortality and Events With Statin Treatments
Edward J. Mills et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis
Anne B. Rossebo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma
Ralf Schmidmaier et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Effect of statin therapy on early return of potency after nerve sparing radical retropubic prostatectomy
Sung Kyu Hong et al.
JOURNAL OF UROLOGY (2007)
Statins activate peroxisome proliferator-activated receptor γ through extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase-dependent cyclooxygenase-2 expression in macrophages
Miyuki Yano et al.
CIRCULATION RESEARCH (2007)
Blockade of adaptive defensive changes in cholesterol uptake and synthesis in AME by the addition of pravastatin to idarubicin plus high-dose Ara-C: a phase 1 study
Steven M. Kornblau et al.
BLOOD (2007)
Statins reduce the risk of pancreatic cancer in humans - A case-control study of half a million veterans
Vikas Khurana et al.
PANCREAS (2007)
Triglycerides and the risk of coronary heart disease - 10 158 incident cases among 262 525 participants in 29 Western prospective studies
Nadeem Sarwar et al.
CIRCULATION (2007)
Emerging indications for statins: A pluripotent family of agents with several potential applications
Kosmas I. Paraskevas et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Use of statins and outcome of BCG treatment for bladder cancer
Paul Hoffmann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Statins, fibrates, and melanoma risk: a systematic review and meta-analysis
Scott R. Freeman et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Atorvastatin normalizes endothelial function in healthy smokers
Stefan Agewall et al.
CLINICAL SCIENCE (2006)
Use of hydroxy-methyl-glutaryl coenzyme A reductase inhibitors is associated with risk of lymphoid malignancies
H Iwata et al.
CANCER SCIENCE (2006)
Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial
Haruo Nakamura et al.
LANCET (2006)
Statins, especially atorvastatin, may favorably influence clinical presentation and biochemical progression-free survival after brachytherapy for clinically localized prostate cancer
MA Moyad et al.
UROLOGY (2005)
Anti-inflammatory effects of statins: Clinical evidence and basic mechanisms
MK Jain et al.
NATURE REVIEWS DRUG DISCOVERY (2005)
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins
C Baigent et al.
LANCET (2005)
Simvastatin reduces vasospasm after aneurysmal subarachnoid hemorrhage - Results of a pilot randomized clinical trial
JR Lynch et al.
STROKE (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Effects of statins on vascular function of endothelin-1
F Mraiche et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
Chemical, pharmacokinetic and pharmacodynamic properties of statins: an update
M Schachter
FUNDAMENTAL & CLINICAL PHARMACOLOGY (2005)
Novel cardioprotective effects of pravastatin in human ventricular cardiomyocytes subjected to hypoxia and reoxygenation: Beneficial effects of statins independent of endothelial cells
S Verma et al.
JOURNAL OF SURGICAL RESEARCH (2004)
Serum triglycerides as a risk factor for cardiovascular diseases in the Asia-Pacific region
A Patel et al.
CIRCULATION (2004)
Statins inhibit secretion of metalloproteinases-1,-2,-3, and-9 from vascular smooth muscle cells and macrophages
ZX Luan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells
W Dichtl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with Hypercholesterolemia - Primary prevention cohort study of the Japan Lipid Intervention Trial (J-LIT)
M Matsuzaki et al.
CIRCULATION JOURNAL (2002)
A prospective study of pravastatin in the elderly at risk (PROSPER): Screening experience and baseline characteristics
I Ford et al.
CURRENT CONTROLLED TRIALS IN CARDIOVASCULAR MEDICINE (2002)
Statin prevents tissue factor expression in human endothelial cells -: Role of Rho/Rho-kinase and Akt pathways
M Eto et al.
CIRCULATION (2002)
Relationship between lipid levels and clinical outcomes in the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) trial - To what extent is the reduction in coronary events with pravastatin explained by on-study lipid levels?
RJ Simes et al.
CIRCULATION (2002)
Statins have biphasic effects on angiogenesis
M Weis et al.
CIRCULATION (2002)
Downregulation of angiotensin II type 1 receptor by hydrophobic 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in vascular smooth muscle cells
T Ichiki et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2001)
HMG-CoA reductase inhibitor mobilizes bone marrow-derived endothelial progenitor cells
J Llevadot et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-I
G Martin et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial
D Hunt et al.
ANNALS OF INTERNAL MEDICINE (2001)
Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study
EJG Sijbrands et al.
BMJ-BRITISH MEDICAL JOURNAL (2001)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Serum triglycerides and risk of coronary heart disease among Japanese men and women
H Iso et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2001)
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma
WS Kim et al.
INVESTIGATIONAL NEW DRUGS (2001)
HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells
T Bourcier et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2000)
Share Paper
